Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.MiMedx Group has received the FDA's clearance to market the Paradis Vaso Shield device, indicated for use as a cover for vessels following anterior vertebral surgery.
Subscribe to our email newsletter
The proprietary, patented, and biocompatible polyvinyl alcohol polymer (PVA) membrane may reduce the risk of associated injury following anterior vertebral surgeries by providing a vessel cover, the company said.
According to MiMedx, the Paradis Vaso Shield is a permanent and biocompatible implant which is suitable as a cover for vessels.
Parker Petit, chairman, president and CEO of MiMedx Group, said: “This is MiMedx Group’s first product to receive FDA clearance. In my opinion, the company has a complement of exciting new technologies, and a number of our products will proceed to the clearance and approval process in 2009. We will keep our shareholders fully informed on our progress.”